New Blood: Former Novartis Exec Transitions to Rubius Therapeutics
New Red-Blood-Cell-Derived Therapies Are Poised to Launch Rubius into the Spotlight.
Improving Human Health: The Promise of Epigenetics
A New Perspective for Genomic Research from Prof. Shankar Balsubramanian
Translating Innovation into Therapies
Antimicrobial Resistance and Drug Commercialization Were Key Topics at the Recent ON Helix Conference in Cambridge, U.K.
Literature Review: Dielectrophoresis to the Fore
Old Methodology Resurrected to Allow Inexpensive Label-Free Separation of Cell Populations
- WaferGen Biosystems
- 7400 Paseo Padre Parkway
- Fremont CA, 94555
- UNITED STATES
Increasing interest in personalized medicine has led to the need for accurate, highly sensitive, high-throughput gene expression data by researchers, clinicians and pharmaceutical companies. WaferGen is addressing that need with the SmartChip System. It is the first system to combine the high-throughput capability and cost efficiencies of microarrays, with the sensitivity and accuracy of real-time PCR, enabling researchers to advance from biomarker discovery to target validation on a single integrated platform.